Unraveling the multifaceted impact of tuberculosis on coinfections
Abstract
Tuberculosis (TB) remains the leading cause of death worldwide from a single bacterial agent. However, an estimated one-quarter of the world's population carries an asymptomatic form of TB. In this state, the host maintains a chronic inflammatory lung environment in which the infection is contained and may even be cleared. TB can be lifelong; thus, patients are likely to contract superinfection by another pathogen. It is therefore relevant to investigate the impact of Mycobacterium tuberculosis ( Mtb ), the bacterium responsible for TB, on the host's capacity to cope with a second infectious agent. TB is increasingly recognized as a dynamic disease that exists along a broad clinical and immunological spectrum, far beyond the conventional dichotomy of active and latent infection. Yet, in the context of coinfections, this complexity is often overlooked. This review therefore bridges historical outbreaks, global epidemiology, and experimental models to illustrate the interplay between TB and co-occurring infections. In particular, Mtb infection shapes the outcome of secondary infections, while coinfecting pathogens can in turn reshape TB progression, immune control, and disease severity.
Related
- Multifaceted Impact of MicroRNA 493-5p on Genome-Stabilizing Pathways Induces Platinum and PARP Inhibitor Resistance in BRCA2-Mutated Carcinomas
- The Impact of Isoniazid Preventive Therapy on Tuberculosis Infection and Disease Progression
- Coinfections With Respiratory Syncytial Virus in a Cohort of Adults With High‐Risk Conditions, 2015–2020: A Retrospective Observational Study
- The frequency of coinfections in patients with coronavirus disease 2019 in intensive care units: Meta-analysis
- Global impact and cost-effectiveness of tuberculosis interventions
BibTeX
@article{fine2026unraveling,
title = {{Unraveling the multifaceted impact of tuberculosis on coinfections}},
author = {Joan Fine and François Trottein and Arnaud Machelart and Valentin Sencio},
journal = {iScience},
year = {2026},
month = oct,
doi = {10.1016/j.isci.2026.117133},
url = {https://hal.science/hal-05805865v1},
note = {CC BY},
}
RIS
TY - JOUR
TI - Unraveling the multifaceted impact of tuberculosis on coinfections
AU - Joan Fine
AU - François Trottein
AU - Arnaud Machelart
AU - Valentin Sencio
PY - 2026
DA - 2026/10/19
JO - iScience
DO - 10.1016/j.isci.2026.117133
UR - https://hal.science/hal-05805865v1
AB - Tuberculosis (TB) remains the leading cause of death worldwide from a single bacterial agent. However, an estimated one-quarter of the world's population carries an asymptomatic form of TB. In this state, the host maintains a chronic inflammatory lung environment in which the infection is contained and may even be cleared. TB can be lifelong; thus, patients are likely to contract superinfection by another pathogen. It is therefore relevant to investigate the impact of Mycobacterium tuberculosis ( Mtb ), the bacterium responsible for TB, on the host's capacity to cope with a second infectious agent. TB is increasingly recognized as a dynamic disease that exists along a broad clinical and immunological spectrum, far beyond the conventional dichotomy of active and latent infection. Yet, in the context of coinfections, this complexity is often overlooked. This review therefore bridges historical outbreaks, global epidemiology, and experimental models to illustrate the interplay between TB and co-occurring infections. In particular, Mtb infection shapes the outcome of secondary infections, while coinfecting pathogens can in turn reshape TB progression, immune control, and disease severity.
SN - 2589-0042
ER -